Deerfield Healthcare Technology Acquisitions Corp.
Status: Deal Closed
U=S+W/5
W=S@11.5
| IPO Proceeds, $M | $143.75M |
|---|---|
| IPO Date | Jul 16, 2020 |
| CEO | Steven Hochberg |
| Left Lead | Deutsche Bank |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | CareMax Medical Group, IMC Medical Group Holdings |
| Deal Announced | Dec 18, 2020 |
| Deal Size, $M | $692.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Jun 4, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jun 8, 2021 |
Formerly DFHT
CMAX
CMAXW
| Price | $0.73 $0.02 |
|---|---|
| Last closing price | $0.80 |
| H/L, 52-week | $1.79 / $6.90 |
| Volume, today | 188,704 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Deerfield Healthcare Technology Acquisitions Corp.:
- Structure and cap table
- 6 directors & officers
- 22 filings and events
- 2 underwriters
- 4 deal advisors
- 4 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Richard Barasch | 65 | Executive Chairman |
| Steven Hochberg | President, Chief Executive Officer and Director | |
| Christopher Wolfe | Chief Financial Officer and Secretary | |
| Dr. Peter J. Fitzgerald | Director | |
| Dr. Linda Grais | Director | |
| Hon. Dr. David J. Shulkin | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Deutsche Bank | Joint BR | 8,125,000 | units |
| UBS | Joint BR | 4,375,000 | |
| 12,500,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.